Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tongjiang Granules for Non-erosive Gastroesophageal Reflux Disease (Liver-Stomach Stagnant Heat Pattern)
CTR20243905Phase 3Active
- Sponsor
- Jianmin Pharmaceutical Group
- Start
- Nov 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of tongjiang granule in gastroesophageal reflux disease (GERD), sponsored by Jianmin Pharmaceutical Group. Started Nov 2024; status: active.
02
Drugs
tongjiang granule
03
Conditions
gastroesophageal reflux disease (GERD)
Beyond the preview
Go deeper on CTR20243905.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20243905.